Family Medicine · San Jose, CA
NPI
1609888411
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
60 N 13th Street, Suite B
San Jose, CA, 95112
Phone (408) 294-2616
Medicare paid, 2024
$45K
595 services
Medicare patients, 2024
109
Average age 77
Drug cost, 2024
$3.6M
10,934 prescriptions
Company payments, 2025
$3,049
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Minh Q Thai was code 99214 (office e&m - established), 287 times for 99 patients. In total Minh Q Thai billed 595 services in 10 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 287 | 99 | $95.88 | $28K |
| 99213 Office E&M - Established | Office | 190 | 83 | $72.58 | $14K |
| 90656 Vaccine Product | Office | 31 | 31 | $21.90 | $679 |
| G0008 Administration of influenza virus vaccine | Office | 31 | 31 | $39.07 | $1,211 |
| 96372 Injection Administration | Office | 29 | 17 | $13.34 | $387 |
| 99204 Office E&M - New | Office | 20 | 20 | $64.60 | $1,292 |
By year: 2022 $59K for 867 services; 2023 $49K for 660 services; 2024 $45K for 595 services.
Medicare prescription drug claims, 2024
In 2024, the drug Minh Q Thai prescribed most often to Medicare patients was Atorvastatin Calcium, with 877 prescriptions and refills. In total Minh Q Thai wrote 10,934 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 877 | 2,236 | 210 | $5,249 |
| Amlodipine Besylate Generic | 627 | 1,559 | 158 | $1,870 |
| Losartan Potassium Generic | 543 | 1,340 | 140 | $3,383 |
| Vascepa Icosapent Ethyl | 467 | 825 | 97 | $287K |
| Farxiga Dapagliflozin Propanediol | 443 | 662 | 82 | $369K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 377 | 987 | 97 | $4,555 |
| Zenpep Lipase/Protease/Amylase | 320 | 443 | 77 | $714K |
| Rosuvastatin Calcium Generic | 302 | 710 | 77 | $1,923 |
| Icosapent Ethyl Generic | 286 | 504 | 80 | $103K |
| Creon Lipase/Protease/Amylase | 284 | 397 | 66 | $491K |
| Famotidine Generic | 270 | 662 | 78 | $2,022 |
| Jardiance Empagliflozin | 234 | 277 | 35 | $153K |
| Linzess Linaclotide | 219 | 306 | 50 | $157K |
| Metoprolol Succinate Generic | 212 | 508 | 48 | $1,873 |
| Alendronate Sodium Generic | 211 | 508 | 59 | $855 |
Brand drugs: 3,743 claims; generic drugs: 7,125 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Minh Q Thai $3,049 ($3,049 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $892.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 44 | $892 |
| AstraZeneca Pharmaceuticals LP AZN | 41 | $890 |
| Novo Nordisk Inc NVO | 6 | $343 |
| Aimmune Therapeutics, Inc. | 14 | $315 |
| GlaxoSmithKline, LLC. GSK | 8 | $191 |
| Gilead Sciences, Inc. GILD | 1 | $132 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $68.1 |
| Amgen Inc. AMGN | 2 | $57.47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $46.45 |
| IBSA Pharma Inc. | 2 | $46.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.